MedTrace Logo

Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Knee Osteoarthritis

NCT01569230 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2012-04-04

No results posted yet for this study

Summary

The purpose of this study is to verify the efficacy and safety of acupuncture treatments (Individualized, Standardized acupuncture) for patients with knee osteoarthritis (OA).

Conditions

  • Osteoarthritis Knee

Interventions

PROCEDURE

Standardized Acupuncture

The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions) 9 Acupuncture points(SP9,GB34, ST36, ST35, Xiyan(EX-LE5), BL60, GB39, SP6 and KI3)were used for all the patients assigned to this group. Sterile Stainless Steel(25mm x 40mm) disposable acupuncture needles manufactured by Dong-Bang Acupuncture Co.(Korea) were used.

PROCEDURE

sham acupuncture

The treatment was applied twice a week for 6 weeks(12sessions). The sham acupuncture was applied on the 9 same acupuncture points as in the standardized acupuncture group. Each session was 20 minutes long

PROCEDURE

Individualized Acupuncture

The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions)

OTHER

Waiting

No interventions were applied to the patients in this group.

Sponsors & Collaborators

  • Semyung University

    collaborator OTHER

  • Ministry of Health & Welfare, Korea

    collaborator OTHER_GOV

  • Eun Jung Kim

    lead OTHER

Principal Investigators

  • Kap-Sung Kim, Ph.D. · Donnguk University Oriental Medical center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-08-31
Completion
2012-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569230 on ClinicalTrials.gov